2,3-O-[(1R,2S,4R)-1,7,7-Trimethylbicyclo[2.2.1]hept-2-ylidene]-D-myo-inositol 1,4,5-Tris(2,2-dimethylpropanoate)

2,3-O-[(1R,2S,4R)-1,7,7-Trimethylbicyclo[2.2.1]hept-2-ylidene]-D-myo-inositol 1,4,5-Tris(2,2-dimethylpropanoate) is a synthetic derivative of myo-inositol, featuring a bicyclic camphor ketal and ester functionalities. The incorporation of these functional groups makes it a useful molecular probe in studying the role of inositol-based phospholipids in cell signaling. Specifically, this compound mimics the behavior of natural inositol phosphates while offering resistance to enzymatic degradation due to its structural modifications. In research, this compound is frequently employed to explain phosphoinositide metabolism and to investigate inositol triphosphate (IP3) signaling pathways. It can function as an analog or inhibitor in experimental models that require precise modulation of inositol phosphate receptors or kinases. By binding to these receptors, it can provide insights into the mechanisms of signal transduction and cellular responses mediated by inositol triphosphate and diacylglycerol. This modified inositol is also valuable in understanding the cross-talk between phosphoinositide signaling and other signaling cascades, like calcium signaling. With its highly specific interactions and the stability offered by its ketal protection, it enables researchers to dissect complex signaling networks, helping to clarify the complex regulation of cellular proliferation, apoptosis, and cytoskeletal dynamics.